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Abstract
Aims/hypothesis—Women with a history of gestational diabetes mellitus (GDM) are advised
to control their weight after pregnancy. We aimed to examine how adiposity and weight change
influence the long-term risk of developing type 2 diabetes after GDM.
Methods—We included 1,695 women who had incident GDM between 1991 and 2001, as part
of the Diabetes & Women’s Health study, and followed them until the return of the 2009
questionnaire. Body weight and incident type 2 diabetic cases were reported biennially. We
defined baseline as the questionnaire period when women reported an incident GDM pregnancy.
We estimated HRs and 95% CIs using Cox proportional hazards models.

Author Manuscript

Results—We documented 259 incident cases of type 2 diabetes during up to 18 years of followup. The adjusted HRs of type 2 diabetes associated with each 1 kg/m2 increase in BMI were 1.16
(95% CI 1.12, 1.19) for baseline BMI and 1.16 (95% CI 1.13, 1.20) for most recent BMI.
Moreover, each 5 kg increment of weight gain after GDM development was associated with a
27% higher risk of type 2 diabetes (adjusted HR 1.27; 95% CI 1.04, 1.54). Jointly, women who
had a BMI ≥30.0 kg/ m2 at baseline and gained ≥5 kg after GDM had an adjusted HR of 43.19
(95% CI 13.60, 137.11), compared with women who had a BMI <25.0 kg/m2 at baseline and
gained <5 kg after GDM.
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Conclusions/interpretation—Baseline BMI, most recent BMI and weight gain after GDM
were significantly and positively associated with risk of progression from GDM to type 2 diabetes.
Keywords
BMI; Gestational diabetes mellitus; Type 2 diabetes mellitus; Weight change

Introduction

Author Manuscript

Gestational diabetes mellitus (GDM) is a common pregnancy complication defined as
glucose intolerance with onset or first recognition during pregnancy [1]. Women who
develop GDM during pregnancy probably have reduced insulin secretion and/or chronic
insulin resistance before pregnancy [2, 3]. As a result, they are at substantially increased risk
of developing type 2 diabetes later in life [4]. One-third of women with type 2 diabetes were
found to have a history of GDM [5]. The increasing prevalence of GDM [6–8] parallels the
worldwide epidemic of type 2 diabetes [9]. Women with a history of GDM represent a
‘revealed’ high-risk group for type 2 diabetes [10], because GDM cases are routinely
identified through blood glucose testing between 24 and 28 weeks of gestation [1]. It
remains to be elucidated whether the natural course of the progression from GDM to overt
type 2 diabetes is significantly altered by lifestyle factors.

Author Manuscript

Excess adiposity and weight gain are well-documented risk factors of type 2 diabetes in the
general population [11–15]. Compared with the general population, women who develop
GDM are more likely to be overweight or obese at the time of GDM diagnosis and are more
likely to develop incident overweight or obesity in later life [16]. As a result, women with a
history of GDM are usually advised to control their weight after delivery [1, 16]. The
National Diabetes Education Program (NDEP) recently called for women with a history of
GDM to be referred to a registered dietitian or community programme for weight
management [17]. A similar recommendation was also given by the American Diabetes
Association (ADA) [1]. Despite these recommendations, weight gain is common among
women with a history of GDM after the index pregnancy and throughout their lifespan [16,
18]. The long-term risk of type 2 diabetes in association with adiposity and weight change
among women with a history of GDM has not been clearly characterised [19].
In this study, we used data from the Nurses’ Health Study (NHS) II cohort to examine the
associations of BMI at baseline and follow-up, as well as weight change after GDM, with
long-term risk of type 2 diabetes among women with a history of GDM.

Author Manuscript

Methods
Study population
The study population was composed of women with a history of GDM in NHS II, as part of
the ongoing Diabetes & Women’s Health study [20], which aims to identify determinants of
the progression from GDM to type 2 diabetes. NHS II, established in 1989, is an ongoing
prospective cohort study of 116,671 female nurses aged 25–44 years at study initiation [21].
Participants receive a biennial questionnaire to update information on health-related
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behaviours and disease outcomes. The follow-up rate for each questionnaire cycle was
greater than 90% up to 2009. This study was approved by the Partners Human Research
Committee (Boston, MA, USA), with participants’ consent implied by the return of the
questionnaires.
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Women were eligible for inclusion if they reported incident GDM from 1991 to 2001. They
were followed up until the return of the 2009 questionnaire. The 2001 questionnaire was the
last time questions regarding GDM were included, as the majority of NHS II participants
had passed reproductive age by then. In a prior validation study, 94% of self-reported GDM
cases were confirmed by medical records [21]. In a random sample of parous women
without GDM, 83% reported a glucose screening test during pregnancy and 100% reported
frequent prenatal urine screening, suggesting a high level of GDM surveillance in this cohort
[21]. We excluded women from the analytical population if they had: (1) prevalent GDM in
1989; (2) type 2 diabetes, cardiovascular disease or cancer prior to their GDM pregnancy or
before the return of their first post-GDM questionnaire; or (3) a multiple gestation (twins or
triplets). Electronic supplementary material (ESM) Fig. 1 briefly outlines the data collection
and follow-up of the study population.
Assessment of exposures

Author Manuscript

The NHS II participants reported their weight and height in the 1989 questionnaire and they
further updated their current weight on each biennial questionnaire. Only 2–4% of the study
participants who responded to the questionnaire had missing data on body weight across the
follow-up years. Self-reported weight was highly correlated with technician-measured
weight (r=0.97) among a subset of NHS cohort participants [22]. BMI was computed as
weight in kilograms divided by the square of height in metres (kg/m2). We classified the
participants’ BMI into the categories <18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9, 35.0–39.9 and
≥40.0 kg/m2, corresponding to definitions of underweight, normal weight, overweight, class
I obesity, class II obesity and class III obesity, respectively, according to National Institutes
of Health guidelines [23]. Since only 1% of the participants had a BMI <18.5 kg/m2, we
merged this category and 18.5–24.9 kg/m2 into BMI <25.0 kg/m2 to ensure statistical power
in the present analysis.

Author Manuscript

Information on age, smoking status, age at first birth, reproductive history, oral
contraceptive use and menopausal status was biennially updated from 1989. Parity was
defined as the number of pregnancies lasting greater than 6 months. Race/ethnicity data
were collected in 1989, and family history of diabetes was collected in 1989 and updated in
2005. Diet information was updated every 4 years since 1991 using a semi-quantitative food
frequency questionnaire (FFQ). The FFQ is designed to measure average dietary intake over
the past year and has been extensively validated [24–26]. To characterise overall diet
quality, we created a summary diet score in terms of the Alternate Healthy Eating Index
2010 (AHEI), as previously described [27]. Total physical activity was ascertained in 1991,
1997 and every 4 years thereafter by frequency of engaging in common recreational
activities, from which metabolic equivalent task-hours per week were derived. The
questionnaire-based estimates correlated well with detailed activity diaries in a prior
validation study (r=0.56) [28].
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Participants reporting physician-diagnosed type 2 diabetes on each biennial questionnaire
were mailed a supplemental questionnaire regarding symptoms, diagnostic tests and
hypoglycaemic therapy to confirm self-reported diagnoses. Confirmed diabetes required at
least one of the following reported on the supplementary questionnaire according to ADA
criteria [29]: (1) one or more classic symptoms (excessive thirst, polyuria, weight loss,
hunger, pruritus or coma) plus elevated glucose levels (fasting plasma glucose concentration
≥7.0 mmol/l or random plasma glucose ≥11.1 mmol/l); or (2) no symptoms reported but two
or more elevated plasma glucose concentrations on more than one occasion (fasting ≥7.0
mmol/l, random ≥11.1 mmol/l, 2 h OGTT ≥11.1 mmol/l); or (3) treatment with insulin or an
oral hypoglycaemic agent. Before 1998, fasting plasma glucose ≥7.8 mmol/l was used
instead of ≥7.0 mmol/l for the diagnosis of diabetes according to the criteria of the National
Diabetes Data Group (NDDG) [30]. In a previous validation study [31], high accuracy
(98%) was observed comparing our classification with medical records according to NDDG
criteria. In a second validation study conducted in 1999, the diagnosis of type 2 diabetes was
confirmed by medical record reviews according to ADA criteria, with high validity (99%).
Statistical analysis

Author Manuscript

In this analysis, baseline was defined as the questionnaire period when women reported an
incident GDM pregnancy during 1991–2001. Therefore, baseline weight was within 2 years
after GDM diagnosis. Weight change since baseline was defined as the most recent body
weight at follow-up minus baseline body weight. We computed follow-up time from the
date of diagnosis of GDM to the date of diagnosis of type 2 diabetes, death, last biennial
questionnaire response or return of the 2009 questionnaire, whichever came first. Updating
of exposure status ceased if a participant reported a diagnosis of chronic disease (e.g.
cardiovascular disease, cancer), because such diagnoses may lead to unintentional or
intentional changes in body weight. If exposure data were missing in one questionnaire
cycle, the values were carried forward from the previous questionnaire for which the data
were captured. However, missing exposure data were not carried forward and were therefore
excluded in the analysis of weight change.

Author Manuscript

We estimated HRs and 95% CIs using Cox proportional hazards models stratified by time
since GDM diagnosis. We conducted tests of linear trend across categories of BMI or weight
change by assigning the median value for each category and fitting this continuous variable
in the models. In the multivariable analysis estimating the effect of updated BMI (i.e. most
recent BMI within 2 years before diagnosis of type 2 diabetes), we adjusted for various
potential confounding factors, including age, parity, age at first birth, race/ethnicity, family
history of diabetes, oral contraceptive use, menopausal status, cigarette smoking,
breastfeeding duration, total energy intake, diet quality (i.e. AHEI score) and physical
activity. All these covariates except race/ethnicity were updated over time. For the analysis
assessing baseline BMI in relation to risk of type 2 diabetes, we adjusted for the baseline
measures of the above variables. To evaluate weight change after GDM in association with
risk of type 2 diabetes, we adjusted for baseline BMI, the aforementioned potential
confounding factors, and simultaneous changes in lifestyle factors, including smoking status
(never to never, never to current, past to past, past to current, current to past, current to
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current), as well as baseline and changes in breastfeeding duration, parity, total energy
intake, diet quality (i.e. AHEI score) and physical activity. Categorical covariates included
an indicator for missing data, if necessary.

Author Manuscript

We evaluated potential effect modification by stratified analyses according to age (<40 years
or ≥40 years), family history of diabetes (yes/no), diet quality (AHEI score, above or below
the median), physical activity (above or below the median), breastfeeding duration (<6
months or ≥6 months) and time since GDM pregnancy (<10 or ≥10 years). To address the
potential bias by medical surveillance for type 2 diabetes, we conducted a sensitivity
analysis restricting the definition of type 2 diabetic cases to participants reporting at least
one diabetic symptom at the time of diagnosis. To min-imise potential bias from subclinical
type 2 diabetes leading to unintentional weight loss, we conducted additional analyses in
which we excluded women who reported type 2 diabetes in the subsequent questionnaire
after reporting GDM: for example, when a woman reported GDM in 1991 and type 2
diabetes in 1993. All statistical analyses were performed using SAS software (version 9.3;
SAS Institute, Cary, NC, USA). A p value <0.05 was considered statistically significant.

Results
During up to 18 years of follow-up (18,596 person-years), we documented 259 incident
cases of type 2 diabetes among 1,695 women with a history of GDM. The mean follow-up
duration was 13.1 years (median 14.0 years). At baseline, women with higher BMI were
older, less physically active and more likely to have a family history of diabetes. They had
lower diet quality and shorter breastfeeding duration (Table 1). During follow-up, we
observed an average weight gain of 0.47 kg per year after the index GDM pregnancy.

Author Manuscript
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Both baseline and updated BMI were strongly and positively associated with future risk of
type 2 diabetes. Figure 1 depicts the unadjusted cumulative incidence of type 2 diabetes
according to baseline BMI. After adjustment for age, parity and other major diabetic risk
factors, women who had a baseline BMI 25.0–29.9, 30.0–34.9, 35.0–39.9 and ≥40.0 kg/m2,
compared with women having a baseline BMI <25.0 kg/m2, had adjusted HRs of 3.62 (95%
CI 2.22, 5.91), 6.72 (95% CI 3.97, 11.37), 15.28 (95% CI 8.52, 27.41) and 17.28 (95% CI
8.63, 34.60), respectively (p for linear trend <0.001). When baseline BMI was modelled as a
continuous variable, each 1 kg/m2 increase in baseline BMI was associated with a 16%
higher risk of type 2 diabetes (HR 1.16; 95% CI 1.12, 1.19) (Table 2; ESM Fig. 2). A similar
association of type 2 diabetic risk was observed for updated BMI. Women with an updated
BMI of 25.0–29.9, 30.0–34.9, 35.0–39.9 and ≥40.0 kg/m2, compared with women with an
updated BMI of <25.0 kg/m2, had adjusted HRs of 3.82 (95% CI 2.08, 7.03), 9.69 (95% CI
5.17, 18.16), 14.68 (95% CI 7.47, 28.88) and 25.97 (95% CI 12.62, 53.44), respectively. The
adjusted HR of type 2 diabetes associated with each increment of 5 kg/m2 in updated BMI
was 1.16 (95% CI 1.13, 1.20).
Weight gain after GDM was significantly associated with risk of type 2 diabetes (Table 3).
After adjustment for baseline BMI and other major diabetic risk factors, the adjusted HRs of
type 2 diabetes associated with weight gain of 2.6–4.9, 5.0–9.9 and ≥10.0 kg were 1.17
(95% CI 0.53, 2.56), 1.48 (95% CI 0.72, 3.03) and 1.99 (95% CI 0.94, 4.25), respectively (p
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for linear trend=0.02), compared with maintaining a stable body weight (±2.5 kg) since
baseline. An increment of 5 kg weight gain after GDM development was associated with a
27% higher risk of type 2 diabetes (HR 1.27; 95% CI 1.04, 1.54). In the analysis of joint
effect of baseline BMI and subsequent weight gain on risk of type 2 diabetes, women who
had a BMI ≥30.0 kg/m2 at baseline and gained ≥5 kg after GDM had an adjusted HR of
43.19 (95% CI 13.60, 137.11), compared with women who had a BMI <25.0 kg/m2 at
baseline and gained <5 kg after GDM (Fig. 2).

Author Manuscript

The positive associations of BMI and weight change with risk of type 2 diabetes persisted
across different categories of age, family history of diabetes, diet quality, physical activity,
breastfeeding duration and time since GDM pregnancy. Moreover, the observed associations
were robust in multiple sensitivity analyses. First, to minimise potential bias from
subclinical type 2 diabetes before GDM diagnosis, we conducted a sensitivity analysis by
excluding women who reported type 2 diabetes in the next questionnaire after reporting
GDM, and found that the multivariable-adjusted HRs across categories of BMI or weight
change were not appreciably changed. Second, sensitivity analyses restricted to women
reporting at least one symptom of diabetes at diagnosis yielded similar results to those for all
cases.

Discussion

Author Manuscript

In this prospective cohort study with up to 18 years of follow-up, we found that both initial
BMI within 2 years after diagnosis of GDM and the most recent BMI before diagnosis of
type 2 diabetes were positively and strongly associated with a greater risk of type 2 diabetes
among women with a history of GDM. Moreover, we observed that weight gain after GDM
was significantly associated with risk of type 2 diabetes. These associations were
independent of other major risk factors of type 2 diabetes, including lifestyle factors such as
diet and physical activity.

Author Manuscript

The associations of BMI and weight change with risk of type 2 diabetes among women with
a history of GDM, a population at high risk of type 2 diabetes, have not been
comprehensively examined. A subgroup analysis of the Diabetes Prevention Program (DPP)
randomised clinical trial showed that intensive lifestyle intervention including diet, physical
activity and weight loss reduced the incidence of type 2 diabetes over 3 years among women
with impaired glucose tolerance and a history of GDM [32]. Although another analysis from
the overall DPP population showed that weight loss was the predominant predictor of
diabetic risk reduction, independently of diet and physical activity [33], it was unclear
whether that was the case in a high-risk population who may have reduced insulin secretion
and/or chronic insulin resistance before pregnancy, i.e. women with a history of GDM. In
the present study, we observed significant associations of BMI and weight change with the
risk of progression from GDM to type 2 diabetes, which were independent of a healthful
dietary pattern and physical activity, two major modifiable risk factors that have been
inversely associated with risk of type 2 diabetes among women with a history of GDM [34,
35]. Furthermore, our findings support the recent call to action from the NDEP which
underlines the importance of postpartum weight management after GDM [17].
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Our findings were consistent with those of previous reports among women with a history of
GDM that examined the associations of risk of type 2 diabetes with baseline BMI before
pregnancy or shortly after the GDM pregnancy [36–41], most recent BMI [42] and weight
change since baseline [37, 40, 43]. With longitudinal data on body weight, type 2 diabetic
status and other major diabetic risk factors, which may be potential confounders, during 18
years of follow-up, our study had the unique opportunity to comprehensively examine the
long-term risk of exposures including BMI, weight change and their joint effects on
progression from GDM to type 2 diabetes. Our findings highlight the importance of
controlling both initial weight and weight gain in the prevention of type 2 diabetes among
women with a history of GDM.
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Strengths of this study include its prospective cohort design, long-term follow-up, the high
response rate of each questionnaire cycle, and comprehensive data that were longitudinally
collected over decades. In addition, the NHS II participants are registered nurses, reducing
potential confounding by educational attainment or differential access to healthcare. We
acknowledge that there are limitations. First, body weight was self-reported in this study.
However, self-reported weight was previously validated against technician-measured weight
with a high correlation (r=0.97) among a subset of NHS cohort participants [22].
Nonetheless, because of the prospective nature of the study design, misclassifications of the
exposure would be non-differential. As such, the observed associations of BMI and weight
gain with type 2 diabetes were more likely to be underestimated. The outcome, physiciandiagnosed type 2 diabetes, was also on the basis of self-report. However, it was confirmed
by supplemental questionnaires including diabetes-related symptoms, glucose testing and
glucose-lowering treatments. Specifically, in the study population of US female nurses, 98%
of self-reported type 2 diabetic events were confirmed by medical records [31]. Second,
BMI may not be able to accurately define obesity, in particular body fat distribution [44].
However, a previous meta-analysis of 32 studies has shown that although the clinical
perspective focusing on central obesity is appealing, BMI and central obesity indicators have
similar associations with incident diabetes [45]. Third, our study population consists mostly
of white American women, thus the generalisation of our findings to other ethnic groups
needs further evaluation. Fourth, screening bias may exist, because women who were more
health-conscious, and therefore visited a physician more regularly, might have been more
likely to receive a medical diagnosis than those who were less health-conscious. However,
we found similar results in our sensitivity analyses restricting cases to symptomatic type 2
diabetes, minimising concerns for this bias.
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In conclusion, among women with a history of GDM, we observed significant and positive
associations of risk of type 2 diabetes with initial BMI within 2 years after diagnosis of
GDM, the most recent BMI before diagnosis of type 2 diabetes and weight gain after GDM.
Our findings provide evidence to support the recent call from NDEP and highlight the
importance of achieving and maintaining a healthy weight in these high-risk women to
prevent future development of type 2 diabetes.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.

Unadjusted cumulative incidence of type 2 diabetes, according to baseline BMI, among
women with a history of GDM. Red line, BMI <25.0 kg/m2; green line, BMI 25.0–29.9
kg/m2; blue line, BMI 30.0–34.9 kg/m2; cyan line, BMI 35.0–39.9 kg/m2; purple line, BMI
≥40.0 kg/m2
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Fig. 2.

Author Manuscript

Joint effect of baseline BMI and weight gain after GDM in association with long-term risk
of progression from GDM to type 2 diabetes. White bars, weight gain <5 kg after GDM;
grey bars, weight gain ≥5 kg after GDM. The error bars indicate 95% CIs. The reference
group was women who had a BMI <25.0 kg/m2 at baseline and gained <5 kg after GDM
(including weight loss and no change). Covariates in the multivariable model include: age
(months), age at first birth (12–24, 25–29 or ≥30 years), race/ethnicity (white, AfricanAmerican, Hispanic, Asian, others), family history of diabetes (yes, no), oral contraceptive
use (current, former, never), menopausal status (premenopausal, postmenopausal), change in
cigarette smoking status (never to never, never to current, past to past, past to current,
current to past, current to current), parity at baseline (1, 2, 3+), change in parity (0, 1, 2+),
and baseline and changes (all in quartiles unless otherwise specified) in breastfeeding
duration (<1, 1–5, 6–11, ≥12 months), total energy intake, diet quality (i.e. AHEI score) and
physical activity
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